Daclatasvir-13C10

SL-761

Daclatasvir-13C10, >98% (CP)

Isotopic Purity : 99 atom % 13C

MDL No. : MFCD30146170

Related CAS No. : [1009119-64-5] of the unlabelled compound

Synonyms : BMS-790052-13C10; BMS-052-13C10; S-1482-13C10; EBP-883-13C10

IUPAC Name : Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate-13C10

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	2495.00		Back Order	Estimated to ship on 01 November 2026
10MG	3895.00		Back Order	Estimated to ship on 01 November 2026

Applications : This is a 13C-labelled analog of Daclatasvir, which is a highly potent inhibitor of hepatitis C virus. It can be used as pharmaceuitical reference standard for the simultaneous quantitation of three novel hepatitis C antivirals, Daclatasvir, Asunaprevir, and Beclabuvir in human plasma by using multiplexed LC-MS/MS method.

References : Jiang H. et. al.:J. Pharm. Biomed. Anal., 107, 409,2015.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.